Alpha 2.0
Login Register
» Articles » PMID: 36756927

Concerns on Bebtelovimab (LY-CoV1404) Used to Neutralize Omicron Subvariants

Overview
Journal J Med Virol
Specialty Microbiology
Date 2023 Feb 9
PMID 36756927
Authors
Xuejun Wang
Yang Yang
Zhifei Song
Yiming Wang
Peng Yang
Xinyu Li
Fei Wang
Mingming Wang
Liting Shao
Shengqi Wang
Affiliations
Soon will be listed here.
Citing Articles

An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape.

Deng W, Niu X, He P, Yan Q, Liang H, Wang Y Front Immunol. 2025; 15():1471396.

PMID: 39840032 PMC: 11746035. DOI: 10.3389/fimmu.2024.1471396.

SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs.

Iketani S, Ho D Cell Chem Biol. 2024; 31(4):632-657.

PMID: 38640902 PMC: 11084874. DOI: 10.1016/j.chembiol.2024.03.008.

Generation and Characterization of a Multi-Functional Panel of Monoclonal Antibodies for SARS-CoV-2 Research and Treatment.

Patterson L, Dubansky B, Dubansky B, Stone S, Kumar M, Rice C Viruses. 2024; 16(1).

PMID: 38257764 PMC: 10821318. DOI: 10.3390/v16010064.

Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations.

Holland S, Holland L, Smith M, Lee M, Hu J, Lim E Microbiol Spectr. 2023; 11(4):e0525822.

PMID: 37306573 PMC: 10434287. DOI: 10.1128/spectrum.05258-22.